Alzheimer’s disease drugs in trial phase II by mechanism of action 2025
收藏Statista2026-04-11 收录
数据链接：
官方服务：
资源简介：
Alzheimer’s disease drugs in clinical trial phase II worldwide as of 2025, by mechanism of action
应用场景：
相关数据集
Brain Delivery and Biodistribution of the Kv1.3 Channel Blocker, HsTX1[R14A], a Potential Therapeutic for Neuroinflammatory Diseases
There are many steps involved in the molecular cascade that causes the clinical symptoms of Alzheimer’s disease, and identifying which step to try to block is complex. Recently, a critical step in the
Monash University Figshare2026-02-11 更新80
The transition midpoint temperature (Tm) calculated from DSC curves of Aβ42 in absence and presence of doliroside A.
The transition midpoint temperature (Tm) calculated from DSC curves of Aβ42 in absence and presence of doliroside A.
Figshare2017-10-31 更新40
Dataset from Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
This multi-center, randomized, double-blind, placebo-controlled parallel-group study will evaluate the effect of gantenerumab (RO4909832) on cognition and functioning and the safety and pharmacokine
NIAID Data Ecosystem20
Systematic Review: Representativeness of Participants in RCTs of Acetylcholinesterase Inhibitors
Objective To determine whether there are differences in age and sex distribution and presence of comorbidities between participants included in randomized controlled trials of acetylcholinesterase inh
NIAID Data Ecosystem80
Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease
Receptor-interacting protein kinase 1 (RIPK1) contributes to a broad set of inflammations and necroptosis in human diseases, which also plays an important role in the pathogenesis of Alzheimer’s disea
NIAID Data Ecosystem40
